
|Articles|January 5, 2022
Tools4Patient Announces Name Change to Cognivia
Advertisement
Cognivia announced a new name for the company formerly known as Tools4Patient. The transition to Cognivia more closely reflects the company's mission to “quantify the power of the mind” and integrate this information into data analyses to optimize and accelerate drug development.
This name change expresses the evolution of the company since it was founded eight years ago. As part of this maturation, Cognivia has built the evidence basis for its technologies through multiple clinical trials and has become a partner of pharma companies, biotechs, and CROs. Cognivia’s solutions are focused in areas that have posed significant challenges to drug development, including the placebo response and medication adherence in clinical trials.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5



